Lieff Cabraser Civil Justice Blog

Lexi Hazam Discusses Benicar Drug at HarrisMartin MDL Conference

Lexi Hazam Discusses Benicar Drug at HarrisMartin MDL Conference

Lieff Cabraser attorney Lexi J. Hazam is speaking at HarrisMartin’s MDL Conference: Zofran, Bard IVC and Zimmer Persona Knee Litigation on July 29, 2015 at Hotel Nikko in San Francisco. Hazam will be featured as a panelist discussing the Benicar (Olmesartan) Litigation. Hazam has been appointed by the court overseeing the nationwide Benicar MDL litigation to the Plaintiffs’ Steering Committee, and serves as Co-Chair of the MDL Plaintiffs’ Science and Experts Committee.

Lexi Hazam Discusses Benicar Side Effect Injuries and Lawsuits

In addition to representing patients prescribed prescription drugs with dangerous, undisclosed side effects, Hazam represents several hundred hip replacement patients in litigation over the DePuy ASR hip replacement (in which the firm has recovered over $30 million for its clients so far), the DePuy Pinnacle metal-on-metal hip device litigation, and the Stryker Rejuvenate implant cases.

Hazam has spoken at several conferences on Benicar injuries as well as the DePuy litigation. She has also spoken on mass torts topics at the Women En Mass conference for women in mass torts, the annual CAOC conference, and the California Lawyer’s Product Liability Roundtable.